Related Experiment Videos
Distinguishing minimal-change disease from mesangial disorders
1University of Utah Health Sciences Center, Salt Lake City.
Kidney International
|September 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Perspectives on blockade of TGFbeta overexpression.
Kidney international·2006
Maximizing hemodynamic-independent effects of angiotensin II antagonists in fibrotic diseases.
Seminars in nephrology·2001
A multi-center cohort study evaluated hemoglobinuria as a marker of inflammation in IgA nephropathy.
Kidney international·2026
Can prevention of disuse atrophy unlock causes of kidney fibrosis?
Kidney international·2026
Toward multilevel therapeutic targeting of medial arterial calcification in chronic kidney disease.
Kidney international·2026
No staining needed: reading kidney injury by its own light.
Kidney international·2026
Can MQ232 guide to novel options for treatment of ADPKD?
Kidney international·2026
EXPRESS: Neutrophil-to-Lymphocyte Ratio as a Biomarker for Early Infection and Subsequent Mortality in Primary Membranous Nephropathy.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2026
Distinct clinical and genetic characteristics of myelodysplastic syndrome in younger patients.
British journal of haematology·2026
Dual-Targeting, Hybrid Antifungal Agents Targeting Candida albicans-An Overview.
Chemical biology & drug design·2026